Our team is comprised of experienced communications professionals and entrepreneurs with a track record of founding successful consultancies and supporting multiple companies in achieving their corporate goals. We have a strong technical understanding driven by a grounding in science and a long history of working in the life sciences industry. This means we understand industry issues and how to navigate complex regulatory landscapes in order to achieve your communications objectives.

Recommendations

“Katja has provided us with invaluable advice in communicating our company’s story to potential investors and partners, helping us to pull together new content for our investor deck, corporate fact sheet and website, in a tight timescale. She is responsive and professional and brings a wealth of insight to her communications counsel”

Graham Griffiths
Chief Business Officer at Vaccitech

“Katja has a broad and deep understanding of the Life Science and Healthcare industry segments and related strategies. She is very effective and well-respected specialist in her domain. It has been inspiring to work with her as there is always a good energy level, commitment to clients challenges and overall professionalism present.”
Tero Silvola
CEO at BC Platforms (a client for over 5 years)

See more recommendations at Linked In.

Client experience

  • Acadia Pharmaceuticals Inc
  • Advicenne SA
  • AstraZeneca plc
  • Atugen AG
  • BC Platforms AG
  • BioInvent International
  • BioSource International Inc (now Invitrogen Inc)
  • Biotechnology Investments Limited
  • BioTie Oy
  • Bluebird Inc
  • Calcivis
  • Cambridge Antibody Technology (now MedImmune)
  • Cytovation A/S
  • Doctors.net.uk
  • DBV Technologies SA
  • Genset SA (now Merck Serono)
  • Healthcare Ventures Ltd
  • Hutchinson Chi-Med
  • Immunocore
  • International Biotechnology Trust
  • Investing in Biotechnology
  • Jurilab Oy
  • London Regenerative Medicine Network
  • McCormick UK
  • Medicxi
  • MedImmune
  • Merck Serono
  • Merlin Biosciences (now Excalibur)
  • Nexstim Oy
  • Novintum BioSciences
  • Noxxon AG
  • Oxford BioMedica plc
  • Oxford Bioscience Network
  • Oxford Immunotec Inc
  • Orquest Inc (now DePuy Inc)
  • Pegasus
  • Physiomics
  • Psioxus
  • Roche Partnering
  • Sarepta Inc
  • Shire Pharmaceuticals
  • SV Health Investors LLP
  • Symphogen DK
  • Zeiss Microscopy